Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Total Liabilities

Latest as of March 2026: CN¥2.05 Billion CNY ≈ $299.66 Million USD

Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has total liabilities worth CN¥2.05 Billion CNY (≈ $299.66 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Yunnan Botanee Bio-Technology Group Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300957 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Capri Holdings Ltd NYSE:CPRI	USA	$3.23 Billion
Zhejiang Semir Garment Co Ltd SHE:002563	China	CN¥6.26 Billion
Wankai New Materials Co. Ltd. SHE:301216	China	CN¥12.74 Billion
Netac Tech SHE:300042	China	CN¥584.94 Million
Northwest Natural Gas Co NYSE:NWN	USA	$4.84 Billion
Turpaz Industries Ltd TA:TRPZ	Israel	ILA347.32 Million
Bure Equity AB ST:BURE	Sweden	Skr270.00 Million
Tibet Urban Development and Investment Co Ltd SHG:600773	China	CN¥6.23 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yunnan Botanee Bio-Technology Group Co L stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yunnan Botanee Bio-Technology Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)

The table below shows the annual total liabilities of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.04 Billion ≈ $298.05 Million	-3.73%
2024-12-31	CN¥2.12 Billion ≈ $309.60 Million	+41.89%
2023-12-31	CN¥1.49 Billion ≈ $218.20 Million	+33.46%
2022-12-31	CN¥1.12 Billion ≈ $163.49 Million	+8.05%
2021-12-31	CN¥1.03 Billion ≈ $151.31 Million	+114.74%
2020-12-31	CN¥481.52 Million ≈ $70.46 Million	+49.16%
2019-12-31	CN¥322.82 Million ≈ $47.24 Million	+3.10%
2018-12-31	CN¥313.11 Million ≈ $45.82 Million	+30.79%
2017-12-31	CN¥239.40 Million ≈ $35.03 Million	--

About Yunnan Botanee Bio-Technology Group Co Ltd

SHE:300957 China Household & Personal Products

Market Cap

$2.06 Billion

CN¥14.10 Billion CNY

Market Cap Rank

#6228 Global

#1309 in China

Share Price

CN¥33.28

Change (1 day)

-0.89%

52-Week Range

CN¥32.58 - CN¥50.85

All Time High

CN¥277.86